
Amanta Healthcare Ltd Upgraded to Hold by MarketsMOJO Amid Technical and Financial Improvements
2026-05-06 08:38:49Amanta Healthcare Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The upgrade, effective from 5 May 2026, is driven by a combination of enhanced technical trends, robust quarterly financial results, attractive valuation metrics, and increased institutional participation, despite some lingering concerns over long-term fundamentals and debt servicing capacity.
Read full news article
Amanta Healthcare Ltd Sees Technical Momentum Shift Amid Strong Price Gains
2026-05-05 08:09:10Amanta Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a strong day change of 6.73% and a current price of ₹140.30, the stock’s technical indicators present a nuanced picture, with bullish signals from MACD and Bollinger Bands contrasting with bearish RSI readings. This article analyses these technical parameters in detail, placing the stock’s performance in the context of broader market trends and its sector.
Read full news article
Amanta Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-05-04 08:02:54Amanta Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.44%, the stock’s recent performance and technical signals suggest a cautious outlook amid mixed momentum cues.
Read full news article
Amanta Healthcare Ltd is Rated Hold
2026-04-27 10:10:52Amanta Healthcare Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Amanta Healthcare Ltd Upgraded to Hold on Technical and Financial Improvements
2026-04-16 08:54:04Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 15 Apr 2026. This change reflects a combination of improved technical indicators, positive quarterly financial results, and a more attractive valuation profile, signalling cautious optimism among investors despite some lingering fundamental challenges.
Read full news article
Amanta Healthcare Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
2026-04-08 08:31:35Amanta Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 7 April 2026. This change reflects a nuanced assessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite some encouraging quarterly financial results, the overall outlook has been tempered by weak long-term fundamentals and a shift in technical momentum.
Read full news article
Amanta Healthcare Ltd Upgraded to Hold on Improved Technicals and Financial Performance
2026-04-03 08:19:20Amanta Healthcare Ltd has seen its investment rating upgraded from Sell to Hold as of 2 April 2026, driven primarily by a marked improvement in technical indicators and encouraging quarterly financial results. The micro-cap pharmaceutical company’s recent performance reflects a cautiously optimistic outlook amid mixed long-term fundamentals.
Read full news article
Amanta Healthcare Ltd is Rated Sell
2026-04-01 10:10:03Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 April 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available







